Results from multiple studies in lung cancer suggest that epithelial phenotype with increased ECAD gene (CDH1) or protein expression, as opposed to mesenchymal or EMT phenotype, is associated with increased sensitivity to EGFR inhibitors [40, 41, 42, 43, 44, 45]. This evidence concerns the gene EGFR and lung carcinoma.